Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR)
agonist that is associated with sedative and analgesic sparing effects, reduced delirium and …

More than 200 studies and reports have been published regarding the use of
dexmedetomidine in infants and children. We reviewed the English literature to summarize …

The introduction of newer more selective α− 2 adrenergic agonist, dexmedetomidine has
made a revolution in the field of anesthesia owing to its varied application. The aim of the …

Background Intraoperative controlled hypotension improves surgical field visibility by
reducing blood loss (efficacy) but poses potential risks linked to organ hypoperfusion …

Objective: A comparative study to evaluate the efficacy of dexmedetomidine as a
hypotensive agent in comparison to esmolol in Functional Endoscopic Sinus Surgery …

Effect of dexmedetomidine combined with sufentanil for post-... : European Journal of
Anaesthesiology | EJA Effect of dexmedetomidine combined with sufentanil for post-caesarean …

Background The surgical stress response plays an important role on the pathogenesis of
perioperative cardiac complications. Alpha‐2 adrenergic agonists attenuate this response …

Objectives/Hypothesis Opioid misuse and diversion is a pressing topic in today's healthcare
environment. The objective of this study was to conduct a review of non‐opioid perioperative …

Objectives: We aimed to evaluate the effects of dexmedetomidine hydrochloride (DEX) on
hemodynamic parameters and on surgeon and patient satisfaction during functional …

Objectives A systematic review of the literature was conducted to evaluate hypotensive
agents in terms of their adverse effects and associations with perioperative morbidity in …